GLP-1 Medications in South Africa: Ozempic, Wegovy, and Mounjaro (2026)

If you're in South Africa and exploring GLP-1 medications, the options just got better. Wegovy and Mounjaro both arrived in 2025, which means you're no longer limited to off-label Ozempic. Here's what's actually available and what you'll pay.

What GLP-1 Medications Are Available in South Africa

The landscape shifted significantly in 2025. Here's the current state:

Previous global semaglutide shortages that affected SA in 2023 and 2024 have largely resolved. Supply is more stable in 2026.

Medical Aid Coverage: What Is and Isn't Covered

This is where it gets practical. South African medical aids cover GLP-1s selectively.

What is covered: Major medical aids (Discovery, Momentum, Vitality, Bonitas) cover Ozempic for type 2 diabetes under chronic medication benefits. The requirement is a confirmed T2D diagnosis with supporting blood work.

What is not covered: Weight management alone (without a T2D diagnosis) is not classified as a Prescribed Minimum Benefit (PMB) condition in South Africa. This means medical aids are not legally required to cover GLP-1s for obesity. In practice, most don't cover it, at least not under standard plans.

If you are using Ozempic or Wegovy purely for weight management without a T2D diagnosis, expect to pay out of pocket.

What Does GLP-1 Cost Out of Pocket in South Africa

For weight management patients paying privately, the monthly cost is significant:

• Ozempic (semaglutide, various doses): R3,000 to R6,000 per month at weight management doses
• Wegovy (semaglutide 2.4mg): similar range, typically R3,500 to R6,000 per month
• Mounjaro (tirzepatide): R3,500 to R6,500 per month depending on dose

These are private script prices at South African pharmacies. Costs vary by pharmacy and by dose. Titration to higher doses increases monthly spend.

For T2D patients on medical aid with chronic benefit approval, medication costs are covered (partially or fully depending on plan). The consultation costs are still typically out of pocket.

How to Get a GLP-1 Prescription in South Africa

Any GP or endocrinologist can prescribe GLP-1 medications in South Africa. For Ozempic and Rybelsus (T2D indications), you need a formal T2D diagnosis. For Wegovy and Mounjaro for weight management, you need a clinical assessment showing:

• BMI above a qualifying threshold (typically 30+, or 27+ with a weight-related condition)
• A discussion of prior weight management attempts
• No contraindications (personal or family history of thyroid cancer, pancreatitis)

There is no specialist-only requirement. Your private GP can prescribe. Telehealth platforms operating in South Africa can also facilitate GLP-1 prescriptions.

Mounjaro and Wegovy: What Arrival in 2025 Actually Changes

Before 2025, the practical GLP-1 landscape in SA was: Ozempic for T2D (covered by medical aid), or Ozempic off-label for weight management (out of pocket, often on a 0.5mg or 1mg dose).

With Wegovy approved specifically for weight management, you now have a labelled product at the 2.4mg dose. This matters for two reasons: prescribers are more comfortable with on-label prescribing, and the conversation with your GP about weight management GLP-1 use is easier.

Mounjaro (tirzepatide) adds a second mechanism. Unlike semaglutide (which is a GLP-1 receptor agonist), tirzepatide activates both GLP-1 and GIP receptors. The dual action produces larger average weight loss in clinical trials than semaglutide. It was approved in SA in October 2025 for both T2D and weight management.

The practical effect: SA patients now have access to the same compound class that produced the biggest trial results, not just the earlier generation.

Tracking Your Dose Titration

GLP-1 medications start at a low dose and titrate up over several weeks. The titration schedule matters: too fast and side effects (nausea, GI distress) become difficult to manage. Too slow and results take longer.

The GLP-1 dose calculator helps you model your titration schedule and understand where you are in the ramp-up. Log each weekly dose in Regimen to track side effects, weight, and how your body responds across the titration curve.

Ready to track your protocol?

• Smart reminders so you never miss a dose
• Progress tracking with photos and weight
• Medication level curves for every compound

Get Regimen Free

Common Questions About GLP-1 in South Africa

Is Ozempic available in South Africa in 2026?
Yes. Ozempic is available via private prescription. It is covered by major medical aids for confirmed type 2 diabetes. For weight management without a T2D diagnosis, it requires a private prescription at out-of-pocket cost.

Is Wegovy available in South Africa?
Yes. Wegovy launched in South Africa in 2025. It is available via private prescription for weight management. It is not covered by medical aid under standard plans as weight management is not a PMB condition in SA.

Is Mounjaro (tirzepatide) available in South Africa?
Yes. Mounjaro was approved in South Africa in October 2025 for both type 2 diabetes and weight management. It is available via private prescription. Cost is approximately R3,500 to R6,500 per month depending on dose.

Does Discovery Health cover Ozempic for weight loss?
Not under standard plans. Discovery and other major medical aids cover Ozempic for type 2 diabetes under chronic medication benefits. Weight management without a T2D diagnosis is not a Prescribed Minimum Benefit, so medical aids are not required to cover it.

What is the difference between Ozempic and Wegovy?
Both contain semaglutide, the same active ingredient. Ozempic is formulated for type 2 diabetes management at doses up to 2mg. Wegovy is formulated specifically for weight management at a higher maintenance dose (2.4mg weekly). Wegovy also has a longer titration schedule designed to minimise side effects during dose escalation.

Tracking Your GLP-1 Protocol

Weekly GLP-1 injections run on a titration schedule that spans several months. Dose changes, side effect patterns, weight trends, and energy shifts all happen over that window. Regimen supports GLP-1 tracking with injection reminders, dose history, weight logging, and Apple Health / Google Health Connect integration.

For TRT in South Africa, see the South Africa TRT guide. For peptides in SA, see the South Africa peptides guide.

This article is for informational purposes only and does not constitute medical advice. Discuss all treatment decisions with your healthcare provider.